Concurrent mRNA overexpression of LANCL2 and EGFR was found in 26.25% (42 of 160 cases) of total GBM samples and 54.55% (42 of 77 cases) of EGFR-overexpressed GBM samples (Fig. 2G). This evidence concerns the gene LANCL2 and glioblastoma.